Enhertu 100 mg

ENHERTU 100 MG is a powder for solution used in intravenous therapy. It contains trastuzumab deruxtecan, a targeted therapy for certain types of cancer. This medication is manufactured by AstraZeneca Canada Inc.

ENHERTU 100 MG is primarily used in the treatment of specific types of cancer. It works by targeting and attacking cancer cells, helping to slow or stop their growth. This medication is often prescribed for patients who have certain genetic markers that make them suitable candidates for this type of therapy. What is ENHERTU used for? It is typically used in advanced stages of cancer where other treatments may not be as effective.

Common effects of ENHERTU 100 MG may include fatigue, nausea, and hair loss. Some patients may also experience a decrease in white blood cells, which can increase the risk of infections. It is important to monitor these effects and report any severe or persistent symptoms to a healthcare provider.

ENHERTU 100 MG should be handled with care and prepared by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of the potential side effects and discuss any concerns with their healthcare provider before starting treatment.

ENHERTU 100 MG may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the effectiveness of this medication.